Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | anti-GPC3-IL15-iC9-expressing CAR T-cells |
Trade Name | |
Synonyms | CATCH T-cells|AGAR T-cells |
Drug Descriptions |
anti-GPC3-IL15-iC9-expressing CAR T-cells are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting GPC3, and co-express IL15 and inducible caspase 9 (iC9), which potentially induce antitumor activity (PMID: 39604730). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C185176 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
anti-GPC3-IL15-iC9-expressing CAR T-cells | anti-GPC3-IL15-iC9-expressing CAR T-cells | 0 | 2 |